S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   115.80 (+4.14%)
MSFT   204.00 (+0.65%)
FB   282.00 (+5.35%)
GOOGL   1,662.50 (+10.04%)
AMZN   3,251.26 (+2.80%)
TSLA   411.00 (+1.23%)
NVDA   520.01 (+2.96%)
BABA   313.33 (+1.75%)
CGC   18.78 (+2.40%)
GE   7.36 (-0.81%)
MU   50.47 (+0.94%)
AMD   78.19 (+2.34%)
T   26.75 (+0.94%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.48 (-0.41%)
NFLX   504.11 (+3.68%)
NIO   31.80 (+15.59%)
BA   148.26 (+0.08%)
DIS   121.64 (+2.68%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   115.80 (+4.14%)
MSFT   204.00 (+0.65%)
FB   282.00 (+5.35%)
GOOGL   1,662.50 (+10.04%)
AMZN   3,251.26 (+2.80%)
TSLA   411.00 (+1.23%)
NVDA   520.01 (+2.96%)
BABA   313.33 (+1.75%)
CGC   18.78 (+2.40%)
GE   7.36 (-0.81%)
MU   50.47 (+0.94%)
AMD   78.19 (+2.34%)
T   26.75 (+0.94%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.48 (-0.41%)
NFLX   504.11 (+3.68%)
NIO   31.80 (+15.59%)
BA   148.26 (+0.08%)
DIS   121.64 (+2.68%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   115.80 (+4.14%)
MSFT   204.00 (+0.65%)
FB   282.00 (+5.35%)
GOOGL   1,662.50 (+10.04%)
AMZN   3,251.26 (+2.80%)
TSLA   411.00 (+1.23%)
NVDA   520.01 (+2.96%)
BABA   313.33 (+1.75%)
CGC   18.78 (+2.40%)
GE   7.36 (-0.81%)
MU   50.47 (+0.94%)
AMD   78.19 (+2.34%)
T   26.75 (+0.94%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.48 (-0.41%)
NFLX   504.11 (+3.68%)
NIO   31.80 (+15.59%)
BA   148.26 (+0.08%)
DIS   121.64 (+2.68%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   115.80 (+4.14%)
MSFT   204.00 (+0.65%)
FB   282.00 (+5.35%)
GOOGL   1,662.50 (+10.04%)
AMZN   3,251.26 (+2.80%)
TSLA   411.00 (+1.23%)
NVDA   520.01 (+2.96%)
BABA   313.33 (+1.75%)
CGC   18.78 (+2.40%)
GE   7.36 (-0.81%)
MU   50.47 (+0.94%)
AMD   78.19 (+2.34%)
T   26.75 (+0.94%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.48 (-0.41%)
NFLX   504.11 (+3.68%)
NIO   31.80 (+15.59%)
BA   148.26 (+0.08%)
DIS   121.64 (+2.68%)
Log in
NASDAQ:TLGT

Teligent Stock Forecast, Price & News

$0.53
-0.07 (-10.88 %)
(As of 10/29/2020 03:59 PM ET)
Add
Compare
Today's Range
$0.53
Now: $0.53
$0.61
50-Day Range
$0.65
MA: $0.86
$1.39
52-Week Range
$0.58
Now: $0.53
$7.00
Volume49,229 shs
Average Volume404,397 shs
Market Capitalization$2.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.68
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. The company is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. Its topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. Teligent, Inc. sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Read More
Teligent logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLGT
CUSIPN/A
Phone856-697-1441
Employees189

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$65.90 million
Book Value($0.99) per share

Profitability

Net Income$-25,120,000.00

Miscellaneous

Market Cap$2.87 million
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$0.53
-0.07 (-10.88 %)
(As of 10/29/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLGT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teligent (NASDAQ:TLGT) Frequently Asked Questions

How has Teligent's stock price been impacted by COVID-19?

Teligent's stock was trading at $3.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TLGT shares have decreased by 83.1% and is now trading at $0.55.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Teligent?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Teligent
.

When is Teligent's next earnings date?

Teligent is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Teligent
.

How were Teligent's earnings last quarter?

Teligent Inc (NASDAQ:TLGT) posted its quarterly earnings data on Wednesday, August, 19th. The company reported ($1.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.70) by $0.16. The firm had revenue of $13.59 million for the quarter.
View Teligent's earnings history
.

When did Teligent's stock split? How did Teligent's stock split work?

Shares of Teligent reverse split before market open on Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 27th 2020. An investor that had 100 shares of Teligent stock prior to the reverse split would have 10 shares after the split.

What guidance has Teligent issued on next quarter's earnings?

Teligent issued an update on its third quarter 2020 Pre-Market earnings guidance on Wednesday, August, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $13.5-13.5 million, compared to the consensus revenue estimate of $14.42 million.

What price target have analysts set for TLGT?

1 brokers have issued 1 year target prices for Teligent's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Teligent's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 263.6% from the stock's current price.
View analysts' price targets for Teligent
.

Are investors shorting Teligent?

Teligent saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 690,600 shares, an increase of 166.2% from the September 30th total of 259,400 shares. Based on an average daily trading volume, of 1,140,000 shares, the days-to-cover ratio is presently 0.6 days. Approximately 13.1% of the shares of the stock are short sold.
View Teligent's Short Interest
.

Who are some of Teligent's key competitors?

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), AbbVie (ABBV), General Electric (GE), Biocept (BIOC), Lannett (LCI), Pfizer (PFE), Selecta Biosciences (SELB) and VBI Vaccines (VBIV).

Who are Teligent's key executives?

Teligent's management team includes the following people:
  • Mr. Jason Grenfell-Gardner M.B.A., M.B.A, Pres, CEO & Director (Age 44)
  • Mr. Stephen Richardson, Chief Scientific Officer (Age 53)
  • Mr. Martin Wilson, Gen. Counsel (Age 42)
  • Mr. Damian Finio, Corp. Sec. & CFO (Age 49)
  • Ms. Nadya Lawrence, Sr. VP of Technical Services (Age 50)

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

How do I buy shares of Teligent?

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teligent's stock price today?

One share of TLGT stock can currently be purchased for approximately $0.55.

How big of a company is Teligent?

Teligent has a market capitalization of $2.97 million and generates $65.90 million in revenue each year. Teligent employs 189 workers across the globe.

What is Teligent's official website?

The official website for Teligent is www.teligent.com.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.